Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with <scp>COPD</scp>

Abstract

While circulating ADMA is higher, NO is lower in COPD and both show a strong correlation to the degree of airflow limitation. ADMA seems to be a possible new marker of prognosis of COPD and can be a novel therapeutic target for the treatment of COPD.